JPMorgan Chase & Co. (JPM) has disclosed a new risk, in the Regulation category.
JPMorgan Chase & Co. faces heightened scrutiny under stringent supervision and regulatory requirements as detailed on pages 4-8 of its 2023 Form 10-K. This includes complexities surrounding unregistered sales of equity securities and the utilization of proceeds, which are critical components of the company’s capital risk management strategy, explored on pages 38-43 of the Form 10-Q and pages 91-101 of the Form 10-K. The firm’s authorization to repurchase up to $30 billion in common shares, as part of its buyback program initiated on May 1, 2022, underscores the ongoing balancing act between regulatory compliance and strategic capital deployment.
Overall, Wall Street has a Strong Buy consensus rating on JPM stock based on 18 Buys and 5 Holds.
To learn more about JPMorgan Chase & Co.’s risk factors, click here.
